Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Inflammation is an essential trigger for POLE-driven ultramutated colorectal cancer

Pathogenic variants in the exonuclease (proofreading) domain of DNA polymerase {varepsilon} (POLE) are frequently detected in colorectal cancers (CRC) with high tumor mutational burden (TMB), yet their functional role in intestinal tumorigenesis remains unknown. Here, we investigated the impact of mutation in POLE on intestinal homeostasis using a conditional mouse model expressing the PoleP286R…

We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.

Read the original at biorxiv.org →

More in Health & Medicine

BDMS invests in gene therapy

Bangkok Dusit Medical Services Plc (BDMS) has invested 170 million baht in General Network Photonics Thailand, a developer of gene therapy for leukaemia treatment, as the hospital group seeks to…

More from Tuesday 20 October →